Trials / Completed
CompletedNCT05454098
Clifutinib Food Effect Study in Healthy Subjects
A Food Effect Phase I Study of the Clifutinib in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Sunshine Lake Pharma Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate to determine the effect of food on the PK of a single dose of 40 mg Clifutinib in healthy subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Clifutinib with fed state | 40 mg Clifutinib with food |
| DRUG | Clifutinib with fasted state | 40 mg Clifutinib without food |
Timeline
- Start date
- 2022-11-08
- Primary completion
- 2022-12-08
- Completion
- 2022-12-08
- First posted
- 2022-07-12
- Last updated
- 2023-03-21
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05454098. Inclusion in this directory is not an endorsement.